¿Es obligatorio publicar el precio unitario de los medicamentos que se adquieren en una licitación pública?

The purpose of this article is to analyze the ruling of the High Court of Justice of the Canary Islands of 28 March 2023, which declares that the Public Procurement Act does not require the publication of the unit price of the medicinal products purchased, and that it is permissible to publish only the total price of the contract, without a breakdown of the units purchased. Likewise, this ruling confirms that the reimbursed price (“PVL”) of the medicinal products is obtained from confidential information, so that its disclosure could cause serious harm to the company’s ability to compete, and that this price should be considered a commercial secret worthy of protection.